Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Shenqi Jiangtang Tablet in type 2 diabetes mellitus
ChiCTR2100044493Phase 4Recruiting
- Sponsor
- People's Hospital of Wuhan University
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Shenqi Jiangtang in type 2 diabetes mellitus (T2DM), sponsored by People's Hospital of Wuhan University. Primary endpoints: Fasting plasma glucose, HbA1c and 1 more. Started Mar 2021; status: recruiting.
02
Drugs
Shenqi Jiangtang
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2100044493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044493.